Understanding Gene Therapy Market: Size, Share, Growth, and Trends for 2024

Written by Vikas .h » Updated on: November 19th, 2024

Gene therapy market size was reached at USD 3.61 billion in 2019. The gene therapy industry is projected to grow to USD 35.67 billion by 2027, exhibiting a compound annual growth rate (CAGR) of 33.6 during the forecast period (2020 – 2027). Gene Therapy Market Size, Share & COVID-19 Impact Analysis, By Application (Oncology, Neurology, and Others), By Vector Type (Viral and Non-viral), By Distribution Channel (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2027
Get a free sample report PDF| https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100243
This report includes a comprehensive table of contents, along with figures, tables, and charts, providing insightful analysis. The gene therapy industry development in healthcare market has experienced significant growth in recent years, fueled by factors such as rising product demand, an expanding customer base, and advancements in technology.
Regional Attributes:
U.S
Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)
Asia-Pacific (Japan, China, and Rest of Asia- Pacific)
Rest of World
This report provides actionable growth insights through a comprehensive analysis that includes secondary research, primary interviews with industry stakeholders, and validation using the Fortune Business Insights regional database. It features detailed primary data from market players across the value chain in all regions, as well as insights from industry experts to deliver both qualitative and quantitative information.
Top Key players:
Leading companies in the market prioritize strategic acquisitions to enhance their R&D capabilities and secure a competitive advantage, allowing them to provide innovative products to users. Here is a list of the top companies in the gene therapy industry:
Novartis AG
Spark Therapeutics, Inc.
Biogen
Gilead Sciences, Inc
Amgen, Inc.
Jazz Pharmaceuticals, Inc.
Sarepta Therapeutics
GlaxoSmithKline plc
Other Prominent Players
Research Objectives:
This study aims to comprehensively define, describe, and forecast the Gene Therapy Market across various dimensions, including product, component, delivery mode, type, model, application, interactivity level, setting, and region. It strives to provide detailed insights into the main drivers of market growth, along with the challenges, opportunities, and constraints the market faces. The research will identify potential opportunities for stakeholders and map out the competitive landscape for industry leaders. Additionally, the study will strategically analyze the market structure by profiling key players and assessing their market shares and core strengths.
The research will track and evaluate competitive developments within the gene therapy industry, such as acquisitions, product launches, enhancements, expansions, agreements, collaborations, and partnerships. By offering a detailed overview of these activities, the study aims to equip stakeholders with insights that support strategic decision-making and informed investment choices. Through an in-depth examination of market dynamics and a comprehensive analysis of competitive strategies, the research seeks to improve understanding of the current market landscape and its future prospects.
Quick Buy - Gene Therapy Market Report: https://www.fortunebusinessinsights.com/checkout-page/100243
Key Industry Developments:
June 2021: Biogen Inc. reported positive outcomes from their Phase 3 STAR study of timrepigene emparvovec (BIIB111/AAV2-REP1), an experimental gene therapy for treating choroideremia.
February 2021: Spark Therapeutics announced the dosing of the first study participant in the U.S. as part of an international clinical trial for gene therapy targeting Pompe Disease.
December 2020: Jazz Pharmaceuticals plc and its partner PharmaMar announced positive results from the ATLANTIS Phase 3 study, evaluating Zepzelca in combination with Doxorubicin for small cell lung cancer patients.
Frequently Asked Questions About This Report:
What is the size of the Gene Therapy Market?
How fast is the gene therapy industry growing?
Which segment holds the largest share of the Gene Therapy Market?
Who are the major players in the gene therapy industry?
What are the key drivers behind the growth of the Gene Therapy Market?

Disclaimer:

We do not claim ownership of any content, links or images featured on this post unless explicitly stated. If you believe any content or images infringes on your copyright, please contact us immediately for removal ([email protected]). Please note that content published under our account may be sponsored or contributed by guest authors. We assume no responsibility for the accuracy or originality of such content. We hold no responsibilty of content and images published as ours is a publishers platform. Mail us for any query and we will remove that content/image immediately.